Restoring the dysfunctional endothelium

Elena Osto, Giuseppe Coppolino, Massimo Volpe, Francesco Cosentino

Research output: Contribution to journalArticlepeer-review


Nowdays the endothelium is considered a key determinant of vascular health. NO is the principal mediator of all endothelial protective effects, due to its antinflammatory, antiproliferative, immunomodulatory and vasorelaxant properties. On the contrary, a growing body of evidence suggests that endothelial dysfunction is associated with cardiovascular events. Emerging data suggest that acute coronary syndromes (ACS) may involve a complex interplay between endothelial dysfunction, inflammation and thrombosis. Despite the success in reducing the mortality from acute cardiovascular events, the incidence of cardiovascular disease and its complication continues to increase. New insights into mechanisms of endothelial dysfunction, such as a better understanding of the regulation of vascular sources of oxygen radicals, may lead to novel therapeutic strategies with the potential to improve prognosis. The key pharmacological agents that improve clinical outcome in high-risk patients are statins, ACE-inhibitors or angiotensin receptor antagonists. Compelling scientific evidence suggests that these medications are effective in improving endothelial function. The present review focuses on the potential importance of benefits on endothelium of these medicaments in the management of acute coronary syndromes.

Original languageEnglish
Pages (from-to)1053-1068
Number of pages16
JournalCurrent Pharmaceutical Design
Issue number10
Publication statusPublished - Apr 2007


  • ACEI
  • ARB
  • Atherosclerosis
  • Coronary artery disease
  • Endothelial dysfunction
  • Nitric oxide
  • Review
  • Statin

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Restoring the dysfunctional endothelium'. Together they form a unique fingerprint.

Cite this